Cocrystal Pharma, Inc. (COCP) vs Palatin Technologies, Inc. (PTN)

A side-by-side comparison of Cocrystal Pharma, Inc. and Palatin Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — COCP vs PTN

growth of $100 · dividends reinvested · last 10y
COCP -99.4% (-39.6%/yr)PTN -98.7% (-35.1%/yr)PTN compounded faster over this window
050100150200250Start $10020182020202220242026$1$1
COCP PTN

COCP vs PTN: by the numbers

  • •PTN is the larger company ($17M vs $15M market cap).
  • •Both run net losses; PTN's is the smaller (-63.54% vs -3011.52% net margin).

Metrics side by side

Valuation

MetricCOCPPTN
P/S ratio46.731.29
P/B ratio14.772.54

Profitability

MetricCOCPPTN
Gross margin0.00%99.63%
Operating margin0.00%-65.74%
Net margin-3011.52%-63.54%
ROE-951.92%-125.30%
ROIC-497.29%-125.44%

Growth (annualized)

MetricCOCPPTN
Revenue CAGR (5Y)91.55%N/A
Total return CAGR (5Y)-37.50%-55.41%

Frequently asked

How have COCP and PTN total returns compared?
Over the past 10 years, COCP delivered -39.76% and PTN delivered -35.08% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.